Tenet Healthcare (NYSE: THC) director trades 5,000 shares at $244.96

Rhea-AI Filing Summary

Tenet Healthcare Corp director James L. Bierman reported selling 5,000 shares of Common Stock on July 27, 2026, in an open-market or private transaction at a weighted average price of $244.96 per share. The sales occurred between $244.95 and $245.29 and left him with 31,604 directly owned shares.

Insider Trade Summary

Net Seller: 5,000 shares

Net Sell 1 txn

Insider BIERMAN JAMES L

Role Director

Sold 5,000 shs ($1.22M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	5,000	$244.96	$1.22M

Holdings After Transaction: Common Stock — 31,604 shares (Direct)

Footnotes (1)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $244.95 to $245.29. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 5,000 shares Weighted average price: $244.96 per share Price range: $244.95–$245.29 per share +1 more

4 metrics

Shares sold 5,000 shares Common Stock sale on July 27, 2026

Weighted average price $244.96 per share Aggregate sales price for 5,000 shares

Price range $244.95–$245.29 per share Individual sale prices across multiple transactions

Shares owned after sale 31,604 shares Direct Common Stock holdings following the transaction

Key Terms

weighted average sales price, open market or private transaction, Securities and Exchange Commission

3 terms

weighted average sales price financial

"The price is the weighted average sales price of the aggregate number"

open market or private transaction financial

"transaction code description: Sale in open market or private transaction"

Securities and Exchange Commission regulatory

"the staff of the Securities and Exchange Commission, upon request"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/28/2026 - 08:00 PM Accepted by SEC EDGAR 07/28/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Tenet Healthcare (THC) report in this Form 4?

Tenet Healthcare reported that director James L. Bierman sold 5,000 shares of Common Stock on July 27, 2026. The sale was coded as an open-market or private transaction at a weighted average price of $244.96 per share.

At what prices did James L. Bierman sell Tenet Healthcare (THC) shares?

The reported transaction shows a weighted average price of $244.96 per share for the 5,000 shares. According to the footnote, individual trades occurred at prices ranging from $244.95 to $245.29 across multiple transactions on the same date.

How many Tenet Healthcare (THC) shares does James L. Bierman own after this sale?

Following the sale, James L. Bierman directly owns 31,604 shares of Tenet Healthcare Common Stock. This figure reflects his direct holdings immediately after disposing of 5,000 shares in the July 27, 2026 transaction reported in the Form 4.

Was the Tenet Healthcare (THC) insider sale under a Rule 10b5-1 trading plan?

The Form 4’s Rule 10b5-1 checkbox was not marked, indicating the reported sale was not identified as being made under a Rule 10b5-1 or similar pre-arranged trading plan according to the filing’s metadata.

What type of security did James L. Bierman trade in Tenet Healthcare (THC)?

The transaction involved Common Stock of Tenet Healthcare. Bierman disposed of 5,000 non-derivative shares in an open-market or private transaction, as indicated by the Form 4’s security title and transaction code description.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BIERMAN JAMES L

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/27/2026		S		5,000	D	$244.96(1)	31,604	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $244.95 to $245.29. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener, as Attorney-in-fact for James L. Bierman	07/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)